Portola Pharmaceuticals, Inc. (PTLA) – Financial and Strategic SWOT Analysis Review

Date: 2015-12


Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company. It undertakes the discovery and development of therapeutics for the treatment of cardiovascular, inflammation, and oncology indications. The company’s product portfolio includes Betrixaban, Andexanet Alfa (PRT4445), PRT2607, and PRT2070. Its products Betrixaban and PRT4445 are used in the treatment of thrombosis; PRT207 and PRT2070 are used in the treatment of autoimmune/inflammation diseases such as idiopathic thrombocytopenic purpura, rheumatoid arthritis, systemic lupus erythematosus, asthma and B cell cancers. Portola has partnerships with Biogen Idec, Bristol-Myers Squibb, Pfizer, Bayer, Johnson & Johnson and Aciex Therapeutics, among others. The company is headquartered in South San Francisco, California, the US.

Portola Pharmaceuticals, Inc. Key Recent Developments

Sep 24, 2015: Portola Pharmaceuticals Appoints Dr. David C. Stump to Board of Directors
Aug 04, 2015: Portola Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Jun 15, 2015: Portola Pharmaceuticals Appoints Industry Leader Tao Fu as Executive Vice President, Chief Commercial and Business Officer
May 06, 2015: Portola Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update
Mar 02, 2015: Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Corporate Update

This comprehensive SWOT profile of Portola Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Portola Pharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample